LifeStance Health Group Inc

Análisis de la acción LifeStance Health Group Inc (LFST)

$11.770

+0.031 (+0.26%)Al cierre

Loading chart…
Máximo
11.920
Apertura
11.820
Precio medio ponderado por volumen
11.80
Volumen
3.65M
Capitalización
1.87B
Mínimo
11.695
Importe
43.09M
EV/EBITDA, TTM
23.82

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

Análisis de IA of LifeStance Health Group Inc (LFST)

Comprar

LifeStance Health Group Inc is a good buy right now due to its current price of $11.74 being significantly below analyst price targets, which range up to $19. Additionally, the company's strong revenue growth is evident with a year-to-date change of +68.68% and a one-year change of +127.52%. The main risk is the recent insider selling, with the CTO selling 42,067 shares, representing 17% of his holdings, which may raise concerns about insider confidence.

Métricas de valoración

El PER previsto actual de LifeStance Health Group Inc (LFST) es 52.63, frente a su media de 5 años de 8.55.

PER previsto

Valor razonable
Media 5A P/E
8.55
P/E actual
52.63
Sobrevalorada
104.39
Infravalorada
-87.30

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
35.18
EV/EBITDA actual
23.82
Sobrevalorada
50.66
Infravalorada
19.70

Precio/ventas previsto

Valor razonable
Media 5A P/S
2.29
P/S actual
2.40
Sobrevalorada
3.14
Infravalorada
1.44

Escenarios de precio de Alphio AI para LFST

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%LFST

$8.88

Precio del escenario

B

Base

Base · 50%LFST

$8.02

Precio del escenario

B

Bajista

Bajista · 25%LFST

$6.83

Precio del escenario

Ballenas con LFST en cartera

T

TPG Capital, L.P.

+ Con en carteraLFST

-7.21%

Rentabilidad a 3 meses

I

Integral Health Asset Management, LLC

+ Con en carteraLFST

-8.91%

Rentabilidad a 3 meses

Cronología de eventos

2026-09-09 (ET)

09:00:00

Barclays Acts as Sole Book Running Manager for Offering

07:30:00

LifeStance Health Group to Offer 22.25M Shares of Common Stock

2026-08-10 (ET)

12:30:00

LifeStance Stock Rises 13.2% to $12.27

2026-08-06 (ET)

07:01:00

2026 Consensus Adjusted EBITDA Forecast $215M-$235M

07:01:00

Sees Q3 Adjusted EBITDA of $49M-$59M

Noticias

Preguntas frecuentes sobre LFST, respondidas por Alphio AI

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

LifeStance Health Group Inc is a good buy right now due to its current price of $11.74 being significantly below analyst price targets, which range up to $19. Additionally, the company's strong revenue growth is evident with a year-to-date change of +68.68% and a one-year change of +127.52%. The main risk is the recent insider selling, with the CTO selling 42,067 shares, representing 17% of his holdings, which may raise concerns about insider confidence.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar